Thymic Epithelial Tumor Clinical Trial
Official title:
Clinical Study of Neoadjuvant PD-1 Antibody (Toripalimab) Plus Chemotherapy for Locally Advanced Thymic Epithelial Tumor
This is a phase II, single-arm, open-label study to evaluate the efficacy and safety of neoadjuvant Toripalimab + chemotherapy followed by radical surgery as first-line treatment in patients with locally advanced thymic epithelial tumor.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05446935 -
Intrathoracic Chemotherapy for TETs With Pleural Spread or Recurrence
|
N/A | |
| Not yet recruiting |
NCT06200233 -
Rivoceranib in Patients With Metastatic Thymic Epithelial Tumor
|
Phase 2 | |
| Not yet recruiting |
NCT03212027 -
Preoperative Prediction of of Thymic Epithelial Tumors by Diffusion-Weighted MR Imaging
|
N/A | |
| Recruiting |
NCT02724696 -
French National Observatory of Patients With Thymic Epithelial Tumor
|
||
| Recruiting |
NCT05667948 -
Molecular Analysis and Treatment Options of Thymic Malignancies
|
||
| Recruiting |
NCT06421805 -
Establishing Prospective Mediastinal Tumor Database of PUMCH
|
||
| Recruiting |
NCT04522687 -
Influence of Radiotherapy and Chemotherapy in the Value of Peripheral Blood Lymphocyte Subsets Among Thoracic Cancer
|
||
| Recruiting |
NCT04417660 -
Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma
|
Phase 2 | |
| Not yet recruiting |
NCT04517539 -
Abscopal Effect of SBRT in Combination With rhGM-CSF and INF-α 2b for Metastatic Thymic Epithelial Tumors
|
Phase 2 | |
| Recruiting |
NCT06301945 -
Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors
|
||
| Recruiting |
NCT05104736 -
PT-112 in Subjects With Thymoma and Thymic Carcinoma
|
Phase 2 | |
| Recruiting |
NCT03858582 -
neoadjuvant_thymic Epithelial Tumor
|
Phase 2 | |
| Recruiting |
NCT06311955 -
Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor
|
Phase 2 |